Sun Life Financial operates as a global insurer and asset manager, with results shaped by interest rates, equity markets, and claims trends across Canada, the United States, and Asia. Its quarterly updates matter because they highlight both the stability of fee-based operations and the market-driven swings that can affect reported profit. Heading into Q3 2026, the company was managing higher financing costs from its SLC Management acquisitions amid shifting rate conditions. This report drew attention for whether steady organic growth in health, wealth, and insurance could counter the non-operating pressures on the bottom line.
For the third quarter ended September 30, 2026, Sun Life Financial posted underlying net income of $1.146 billion, an increase of 9% from $1.047 billion in the prior year. Reported net income attributable to common shareholders declined 29% to $785 million from $1.106 billion in Q3 2025. Underlying diluted EPS came in at $1.97 versus $1.86 the year before.
The difference between the two profit figures stemmed mainly from unfavorable interest rate effects, negative ACMA adjustments, and the lack of last year’s one-time gains such as the Bowtie ownership increase. Underlying ROE stood at 18.8% on a year-to-date basis, while reported ROE was 12.8%.
Segment results showed Canada with underlying net income of $422 million (up 6%), the U.S. business at US$141 million (up 32%), and Asia at $226 million (up 7%). The U.S. performance benefited from double-digit premium growth and better morbidity experience in medical stop-loss, while Asia saw continued sales strength in Hong Kong, India, and Malaysia. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
SLF shares remained relatively steady after the release, with modest early gains as investors focused on the resilience of underlying earnings rather than the reported-net-income decline. The measured response indicates that the drop in reported profit was viewed as driven by non-operating factors—primarily interest rate impacts and one-time items—rather than weakness in core operations. Sentiment received support from stronger-than-expected momentum in the U.S. stop-loss business and ongoing growth in Asia, which helped offset concerns over less favorable insurance experience in certain Canadian and U.S. health lines.
Looking ahead, attention will turn to whether Sun Life can maintain its underlying earnings momentum into 2027. The U.S. medical stop-loss segment stands out as a positive area, supported by disciplined pricing and improved claims experience, and its path forward will remain an important variable. In Asia, the pace of individual insurance sales—especially in Hong Kong and bancassurance channels in India and Malaysia—will show whether regional expansion can continue.
Interest rate conditions will stay relevant given their direct effect on reported results through market-related impacts. Any sustained change in yields could ease or add to the pressure seen in the quarter. At the same time, the company’s broader strategy, including a new partnership with Wilton Re and a multi-year commitment to Canadian infrastructure investments, points to efforts to expand insurance and asset management capabilities.
Shareholders may also track capital strength and returns, including the recently announced dividend increase, along with expense and claims trends across health and benefits lines. None of this amounts to a price prediction, but it highlights the areas most likely to influence how the stock performs in coming quarters. From what I see, these factors deserve close attention in future updates.
In my view, tools like Tickeron’s AI Screener help cut through earnings noise by letting investors quickly filter for patterns and fundamentals that align with underlying trends. I ran a quick scan on insurance peers to confirm how Sun Life’s metrics stack up, which added useful context without replacing the full report review. It’s a practical step when sorting through quarterly releases like this one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
SLF moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 22 of 35 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 63%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 58 cases where SLF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 52%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SLF as a result. In 39 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 51%.
The Moving Average Convergence Divergence Histogram (MACD) for SLF turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 27 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 53%.
The 10-day moving average for SLF crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
The Aroon Indicator for SLF entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +2.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where SLF advanced for three days, in 153 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 45%.
SLF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 46 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock slightly better than average.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.680) is normal, around the industry mean (1.633). P/E Ratio (12.370) is within average values for comparable stocks, (14.082). SLF's Projected Growth (PEG Ratio) (1.326) is slightly higher than the industry average of (0.465). Dividend Yield (0.038) settles around the average of (0.061) among similar stocks. P/S Ratio (1.541) is also within normal values, averaging (1.806).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. SLF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a financial conglomerate
Industry MultiLineInsurance